| Year |
Citation |
Score |
| 2020 |
Châtre R, Lange J, Péraudeau E, Poinot P, Lerondel S, Le Pape A, Clarhaut J, Renoux B, Papot S. In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32777236 DOI: 10.1016/J.Jconrel.2020.08.008 |
0.382 |
|
| 2019 |
Lange J, Eddhif B, Tarighi M, Garandeau T, Péraudeau E, Clarhaut J, Renoux B, Papot S, Poinot P. Volatile Organic Compound (VOC)-Based Probe for Induced Volatolomics of Cancers. Angewandte Chemie (International Ed. in English). PMID 31518472 DOI: 10.1002/Anie.201906261 |
0.306 |
|
| 2019 |
Taran F, Porte K, Renoux B, Peraudeau E, Clarhaut J, Eddhif B, Poinot P, Gravel E, Doris E, Wijkhuisen A, Papot S. Controlled Release of Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angewandte Chemie (International Ed. in English). PMID 30856679 DOI: 10.1002/Anie.201902137 |
0.3 |
|
| 2018 |
Renoux B, Fangous L, Hötten C, Péraudeau E, Eddhif B, Poinot P, Clarhaut J, Papot S. A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E. Medchemcomm. 9: 2068-2071. PMID 30746064 DOI: 10.1039/C8Md00466H |
0.333 |
|
| 2018 |
Compain G, Oumata N, Clarhaut J, Péraudeau E, Renoux B, Galons H, Papot S. A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy. European Journal of Medicinal Chemistry. 158: 1-6. PMID 30199702 DOI: 10.1016/J.Ejmech.2018.08.100 |
0.333 |
|
| 2018 |
Koniev O, Dovgan I, Renoux B, Ehkirch A, Eberova J, Cianférani S, Kolodych S, Papot S, Wagner A. Reduction-rebridging strategy for the preparation of ADPN-based antibody-drug conjugates. Medchemcomm. 9: 827-830. PMID 30108971 DOI: 10.1039/C8Md00141C |
0.303 |
|
| 2017 |
Péraudeau E, Cronier L, Monvoisin A, Poinot P, Mergault C, Guilhot F, Tranoy-Opalinski I, Renoux B, Papot S, Clarhaut J. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid. Journal of Controlled Release : Official Journal of the Controlled Release Society. 269: 36-44. PMID 29129656 DOI: 10.1016/J.Jconrel.2017.11.011 |
0.363 |
|
| 2017 |
Kolodych S, Michel C, Delacroix S, Koniev O, Ehkirch A, Eberova J, Cianférani S, Renoux B, Krezel W, Poinot P, Muller CD, Papot S, Wagner A. Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates. European Journal of Medicinal Chemistry. PMID 28818506 DOI: 10.1016/J.Ejmech.2017.08.008 |
0.388 |
|
| 2017 |
Renoux B, Raes F, Legigan T, Péraudeau E, Eddhif B, Poinot P, Tranoy-Opalinski I, Alsarraf J, Koniev O, Kolodych S, Lerondel S, Le Pape A, Clarhaut J, Papot S. Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chemical Science. 8: 3427-3433. PMID 28507714 DOI: 10.1039/C7Sc00472A |
0.362 |
|
| 2017 |
Bezagu M, Clarhaut J, Renoux B, Monti F, Tanter M, Tabeling P, Cossy J, Couture O, Papot S, Arseniyadis S. In situ targeted activation of an anticancer agent using ultrasound-triggered release of composite droplets. European Journal of Medicinal Chemistry. PMID 28416362 DOI: 10.1016/J.Ejmech.2017.03.057 |
0.342 |
|
| 2015 |
Barat R, Legigan T, Tranoy-Opalinski I, Renoux B, Péraudeau E, Clarhaut J, Poinot P, Fernandes AE, Aucagne V, Leigh DA, Papot S. A mechanically interlocked molecular system programmed for the delivery of an anticancer drug. Chemical Science. 6: 2608-2613. PMID 29308165 DOI: 10.1039/C5Sc00648A |
0.356 |
|
| 2015 |
Alsarraf J, Péraudeau E, Poinot P, Tranoy-Opalinski I, Clarhaut J, Renoux B, Papot S. A dendritic β-galactosidase-responsive folate-monomethylauristatin E conjugate. Chemical Communications (Cambridge, England). 51: 15792-5. PMID 26365722 DOI: 10.1039/C5Cc05294G |
0.372 |
|
| 2014 |
Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Molecular Cancer Therapeutics. 13: 2159-69. PMID 25053823 DOI: 10.1158/1535-7163.Mct-13-1038 |
0.316 |
|
| 2014 |
Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, Papot S. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update. European Journal of Medicinal Chemistry. 74: 302-13. PMID 24480360 DOI: 10.1016/J.Ejmech.2013.12.045 |
0.375 |
|
| 2013 |
Grinda M, Legigan T, Clarhaut J, Peraudeau E, Tranoy-Opalinski I, Renoux B, Thomas M, Guilhot F, Papot S. An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process. Organic & Biomolecular Chemistry. 11: 7129-33. PMID 24057011 DOI: 10.1039/C3Ob41536H |
0.333 |
|
| 2013 |
Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Jayle C, Alsarraf J, Thomas M, Papot S. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy. European Journal of Medicinal Chemistry. 67: 75-80. PMID 23845743 DOI: 10.1016/J.Ejmech.2013.06.037 |
0.384 |
|
| 2012 |
Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. Angewandte Chemie (International Ed. in English). 51: 11606-10. PMID 22996951 DOI: 10.1002/Anie.201204935 |
0.317 |
|
| 2012 |
Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S. Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin. Journal of Medicinal Chemistry. 55: 4516-20. PMID 22515366 DOI: 10.1021/Jm300348R |
0.335 |
|
| 2012 |
Grinda M, Clarhaut J, Renoux B, Tranoy-Opalinski I, Papot S. A self-immolative dendritic glucuronide prodrug of doxorubicin Med. Chem. Commun.. 3: 68-70. DOI: 10.1039/C1Md00193K |
0.327 |
|
| 2012 |
Vuong S, Brondel N, Len C, Papot S, Renoux B. Formal synthesis of TMC-69-6H via a one-pot enantioselective domino proline-mediated aldol/olefin homologation procedure Tetrahedron. 68: 433-439. DOI: 10.1016/J.Tet.2011.11.025 |
0.313 |
|
| 2011 |
Renoux B, Legigan T, Bensalma S, Chadéneau C, Muller JM, Papot S. A new cyclopamine glucuronide prodrug with improved kinetics of drug release Organic and Biomolecular Chemistry. 9: 8459-8465. PMID 22042246 DOI: 10.1039/C1Ob06081C |
0.36 |
|
| 2010 |
Hamon F, Renoux B, Chadéneau C, Muller JM, Papot S. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma European Journal of Medicinal Chemistry. 45: 1678-1682. PMID 20116904 DOI: 10.1016/J.Ejmech.2009.12.067 |
0.334 |
|
| 2010 |
PAPOT S, COMBAUD D, GESSON J. ChemInform Abstract: A New Spacer Group Derived from Arylmalonaldehydes for Glucuronylated Prodrugs. Cheminform. 30: no-no. DOI: 10.1002/CHIN.199902251 |
0.547 |
|
| 2009 |
Hamon F, Prié G, Lecornué F, Papot S. Cyanuric chloride: an efficient reagent for the Lossen rearrangement Tetrahedron Letters. 50: 6800-6802. DOI: 10.1016/J.Tetlet.2009.09.115 |
0.319 |
|
| 2008 |
Thomas M, Clarhaut J, Tranoy-Opalinski I, Gesson JP, Roche J, Papot S. Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy. Bioorganic & Medicinal Chemistry. 16: 8109-16. PMID 18692397 DOI: 10.1016/J.Bmc.2008.07.048 |
0.599 |
|
| 2008 |
Tranoy-Opalinski I, Fernandes AE, Thomas M, Gesson JP, Papot S. Design of self-immolative linkers for tumour-activated prodrug therapy Anti-Cancer Agents in Medicinal Chemistry. 8: 618-637. DOI: 10.2174/1871520610808060618 |
0.344 |
|
| 2007 |
Thomas M, Gesson JP, Papot S. First O-glycosylation of hydroxamic acids. The Journal of Organic Chemistry. 72: 4262-4. PMID 17465568 DOI: 10.1021/Jo0701839 |
0.595 |
|
| 2007 |
Thomas M, Rivault F, Tranoy-Opalinski I, Roche J, Gesson JP, Papot S. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy. Bioorganic & Medicinal Chemistry Letters. 17: 983-6. PMID 17157009 DOI: 10.1016/J.Bmcl.2006.11.042 |
0.604 |
|
| 2007 |
Papot S, Thomas M, Gesson J. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates Synlett. 2007: 1966-1968. DOI: 10.1055/S-2007-984534 |
0.593 |
|
| 2007 |
Thomas M, Gesson J, Papot S. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates. Cheminform. 38. DOI: 10.1002/chin.200750198 |
0.558 |
|
| 2006 |
Fernandes A, Marrot J, Gesson J, Papot S. A New Simple and Convenient Method for the Synthesis of Substituted 2,6,9-Trioxabicyclo[3.3.1]-nona-3,7-dienes from Arylmalondialdehydes. Cheminform. 37. DOI: 10.1016/J.Tetlet.2006.06.043 |
0.6 |
|
| 2006 |
Fernandes A, Marrot J, Gesson J, Papot S. A new simple and convenient method for the synthesis of substituted 2,6,9-trioxabicyclo[3.3.1]-nona-3,7-dienes from arylmalondialdehydes Tetrahedron Letters. 47: 5961-5964. DOI: 10.1016/J.TETLET.2006.06.043 |
0.563 |
|
| 2005 |
Combaud D, Thomas M, Papot S, Gesson J. Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy Letters in Drug Design & Discovery. 2: 631-637. DOI: 10.2174/157018005774717271 |
0.571 |
|
| 2003 |
Papot S, Tranoy I, Tillequin F, Florent JC, Gesson JP. Design of selectively activated anticancer prodrugs: elimination and cyclization strategies. Current Medicinal Chemistry. Anti-Cancer Agents. 2: 155-85. PMID 12678742 DOI: 10.2174/1568011023354173 |
0.583 |
|
| 2002 |
Papot S, Rivault F, Tranoy I, Gesson J. Synthesis and β-Glucuronidase Mediated Cleavage of an Alcohol Prodrug Incorporating a Double Spacer Moiety Synlett. 2002: 0164-0166. DOI: 10.1055/S-2002-19327 |
0.581 |
|
| 2001 |
Nicolas LB, Pinoteau W, Papot S, Routier S, Guillaumet G, Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Research. 922: 216-22. PMID 11743952 DOI: 10.1016/S0006-8993(01)03171-7 |
0.364 |
|
| 2001 |
Maguire AR, Plunkett SJ, Papot S, Clynes M, O'Connor R, Touhey S. Synthesis of indomethacin analogues for evaluation as modulators of MRP activity. Bioorganic & Medicinal Chemistry. 9: 745-62. PMID 11310610 DOI: 10.1016/S0968-0896(00)00292-3 |
0.492 |
|
| 2001 |
Papot S, Combaud D, Bosslet K, Gerken M, Czech J, Gesson JP. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard. Bioorganic & Medicinal Chemistry Letters. 10: 1835-7. PMID 10969980 DOI: 10.1016/S0960-894X(00)00353-X |
0.631 |
|
| 2001 |
Maguire AR, Papot S, Ford A, Touhey S, O'Connor R, Clynes M. Enantioselective Synthesis of Sulindac Synlett. 2001: 0041-0044. DOI: 10.1055/S-2001-9722 |
0.329 |
|
| 1999 |
Papot S, Combaud D, Gesson JP. A new spacer group derived from arylmalonaldehydes for glucuronylated prodrugs. Bioorganic & Medicinal Chemistry Letters. 8: 2545-8. PMID 9873577 DOI: 10.1016/S0960-894X(98)00454-5 |
0.615 |
|
| 1999 |
Papot S, Bachmann C, Combaud D, Gesson J. Study of biscarbamates derived from 2-aminobenzylamines as models for alcohol prodrugs Tetrahedron. 55: 4699-4708. DOI: 10.1016/S0040-4020(99)00139-8 |
0.57 |
|
| Show low-probability matches. |